Trending...
- Ismael Cala Foundation and FICOP join forces to enhance the emotional education of young Hispanics USA - English USA - español
- ProtectVirginia Petitions Virginia Dept of Environmental Quality for Cruise Ship Regulations
- Situ Ve Offers a New Perspective on Love Amid the Rising Passport Bro Movement
TALLAHASSEE, Fla. ~ Today, Governor Ron DeSantis and members of the Florida Cabinet approved rules to implement several provisions of the Prescription Drug Reform Act (SB 1550). This bill institutes the most comprehensive reforms to Florida's prescription drug market in state history.
Governor DeSantis stated, "We are committed to making Florida's prescription drug market the most transparent and accountable in the nation. For too long, PBMs and Big Pharma have made extraordinary windfalls by operating behind closed doors — deciding which prescriptions are covered, where they can be purchased, and how much they cost. These rules will continue our efforts to lower prescription costs and make corporations responsible to the patients they serve."
The rules approved today include all application forms for PBMs seeking to operate in Florida after December 31, 2023. Any PBM that attempts to continue operating in Florida on or after January 1, 2024, that has not been approved as an insurance administrator will be subject to fines totaling $10,000 per violation per day. The Office of Insurance Regulation (OIR) also issued additional information to all stakeholders outlining the method by which PBMs must report appeals from network pharmacies and pharmacists and the forms for health plans and payors to annually attest compliance with Florida law.
More on The Floridant
The Department of Business and Professional Regulation initiated rulemaking this summer to implement additional provisions of SB 1550 requiring Big Pharma to provide notice when increasing the cost of prescription drugs. Prescription drug manufacturers must disclose all price hikes that result in a 15% increase within a calendar year or 30% increase within a three-year period both on the effective date of the increase and through an annual cumulative report citing the contributing factor for the reported increases.
Today's approval of rules implementing several provisions of SB 1550 is part of Governor DeSantis' commitment to making Florida's prescription drug market more transparent and accountable. The new regulations will help ensure that PBMs are held responsible for their actions while also providing more information about price increases from Big Pharma so consumers can make informed decisions about their healthcare needs.
Governor DeSantis stated, "We are committed to making Florida's prescription drug market the most transparent and accountable in the nation. For too long, PBMs and Big Pharma have made extraordinary windfalls by operating behind closed doors — deciding which prescriptions are covered, where they can be purchased, and how much they cost. These rules will continue our efforts to lower prescription costs and make corporations responsible to the patients they serve."
The rules approved today include all application forms for PBMs seeking to operate in Florida after December 31, 2023. Any PBM that attempts to continue operating in Florida on or after January 1, 2024, that has not been approved as an insurance administrator will be subject to fines totaling $10,000 per violation per day. The Office of Insurance Regulation (OIR) also issued additional information to all stakeholders outlining the method by which PBMs must report appeals from network pharmacies and pharmacists and the forms for health plans and payors to annually attest compliance with Florida law.
More on The Floridant
- Bug Busters Celebrates 40 Years in the Pest Control Industry
- National Minority Health Association and Cell-Ed Announce Upcoming Webinar: Empowering Caregivers Through Innovative Training Programs
- ROB RUSSELL'S OPEN MIC Promises a 'Spooktacular & Boolicious' Halloween Party
- Free 6-Month Premium Matrimonial Membership Now Available on IndoMarry.com
- NEMTAC Announces Public Comment Period for the NEMTAC 3001-202X Transportation Specialist Education Draft Standard
The Department of Business and Professional Regulation initiated rulemaking this summer to implement additional provisions of SB 1550 requiring Big Pharma to provide notice when increasing the cost of prescription drugs. Prescription drug manufacturers must disclose all price hikes that result in a 15% increase within a calendar year or 30% increase within a three-year period both on the effective date of the increase and through an annual cumulative report citing the contributing factor for the reported increases.
Today's approval of rules implementing several provisions of SB 1550 is part of Governor DeSantis' commitment to making Florida's prescription drug market more transparent and accountable. The new regulations will help ensure that PBMs are held responsible for their actions while also providing more information about price increases from Big Pharma so consumers can make informed decisions about their healthcare needs.
0 Comments
Latest on The Floridant
- Circumference Group Acquires Majority Stake in Visionary Integration Professionals
- Tim O'Loughlin Appointed Chief Executive Officer of Vantiva and Co-opted as a Director of the Board
- New Book Fight Fight Fight-Never Surrender Inspires Patriots and Veterans to Defend American Freedom
- TN Nursery Gears Up for Busy Fall Shipping Season with Nationwide Fast Shipping, Low Grower Prices, and Storewide Deals
- Jazz Artist Bob Holz Signs With SoVibe Entertainment Plus Album Review In September 2024 Issue Of Downbeat Magazine
- 2024 Mount Dora Mayoral Forum Candidates Answer the Burning Questions
- Kalm Pioneers Mental Health Breakthrough with At-Home Ketamine Therapy
- Develop Africa Partners with Sierra Leonean Painter Sahr Songu Mbriwa to Raise Funds for Education
- SAVE Fuel Reduce Pollution Global Warming Only TALK? ECOFUELMAX
- Eminent Jurist Endorses New Method to End the Grind of Legal Calendaring
- Composer Andrew Prahlow to Perform Award-Winning Outer Wilds Soundtrack on Oct 17th at Brooklyn's Music Hall of Williamsburg
- AXELERA Technologies Prepares for AUSA Annual meeting, Showcasing the 3d_4X Joystick
- The New Real Estate "Just Looking" Program Is A Big Hit With Central Florida Residents!
- The Florida Forum Speaker Series to Welcome Rt Hon Boris Johnson
- Mobile windshield service provides welcome post-storm relief
- Cell-Ed and National Minority Health Association Forge Strategic Partnership to Expand Caregiving and Health Equity Initiatives
- Fortius Metals secures $2 Million Additional Funding to Bring Advanced Metal 3D Printing to the Aerospace and Defense Industry
- Voices Rising Festival Celebrates Diversity in E. Islip, GRAMMY Governor LACHI performs!
- DiSTI's GL Studio SC Powers New Guardian UAV Ground Control System
- Innovation & Development for Haiti, INC. Named Kenney Cenat as Speaker for its Fundraising Gala